RxSight Inc. (RXST), an ophthalmic medical device company, will report financial results for the first quarter of 2024 after the market close on Monday, May 6, 2024.
The company markets FDA-approved proprietary RxSight Light Adjustable Lens system, the first and only commercially available intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com